- ►diabetesjournals.org EMM Ooi, GF Watts, DC Chan, MM Chen, PJ … - Diabetes Care, 2008 - Am Diabetes Assoc RESULTS—Compared with placebo, there was a significant dose-dependent
reduction with rosuvastatin in plasma triglyceride and VLDL apoC-III
concentrations. Rosuvastatin significantly (P < 0.05) increased VLDL ... Cited by 2 - Related articles - All 5 versions
E Pau, Y He, M Lougheed, UP Steinbrecher - Biochemistry and cell biology= Biochimie et biologie … - ncbi.nlm.nih.gov It is believed that the major mechanisms by which hydroxymethylglutaryl coenzyme
A reductase inhibitors lower plasma cholesterol levels are by inducing hepatic
low-density lipoprotein (LDL) receptor activity and by decreasing ... Cited by 7 - Related articles - BL Direct - All 4 versions
[CITATION] New insights into the roles of apolipoprotein C-III in stimulating the production of hepatic …
M Sundaram, P Links, MB Khalil, Y Wang, S … - Arterioscler Thromb Vasc Biol, 2007 Cited by 5 - Related articles
AJ Tremblay, B Lamarche, I Ruel, JC Hogue, … - Atherosclerosis, 2004 - Elsevier Increasing evidence suggests that remnants of chylomicrons and very low density
lipoprotein (VLDL) also known as triglyceride-rich lipoproteins (TRL) are
directly related to the pathogenesis of atherosclerosis. While studies in ... Cited by 12 - Related articles - All 4 versions
C Phillips, K Mullan, D Owens, GH Tomkin - Atherosclerosis, 2006 - Elsevier Diabetic subjects had significantly higher MTP mRNA than non-diabetic subjects.
Statin therapy was associated with lower MTP mRNA in both groups. In the
untreated diabetic patients compared to the untreated non-diabetic patients ... Cited by 13 - Related articles - All 10 versions
JA Cortner, MJ Bennett, NA Le, PM Coates - Journal of inherited metabolic disease, 1993 - Springer Summary: Overproduction of very low-density lipoprotein apolipoprotein B by the
liver is a metabolic marker for familial combined hyperlipidaemia, a common
inherited disorder of lipoprotein metabolism. Four subjects with familial ... Cited by 13 - Related articles - BL Direct - All 3 versions
S Benítez, J Ordóñez-Llanos, M Franco, C … - The American journal of cardiology, 2004 - Elsevier The effect of simvastatin therapy on the biologic characteristics of the
electronegative low-density lipoprotein (LDL) subfraction of patients with
familial hypercholesterolemia (FH) was studied. Total LDL, isolated from FH ... Cited by 14 - Related articles - All 7 versions
NR Matthan, M Raeini-Sarjaz, AH … - Lipids, 2000 - Springer ASR in grams/d (g·d −1 ) were strongly associated with lathosterol (r = 0.72
and 0.71, P = 0.0001), desmosterol (r = 0.75 and 0.75, P = 0.0001), lanosterol
(r = 0.67 and 0.67), and squalene (r = 0.69 and 0.68) when levels of the ... Cited by 14 - Related articles - BL Direct - All 3 versions
- ►uwa.edu.au [PDF] CA Dane-Stewart, GF Watts, S Pal, D Chan, … - Metabolism, 2003 - Elsevier We aimed to examine postprandial dyslipidemia in normolipidemic patients with
coronary artery disease (CAD) and the effects of treatment with an hydroxymethyl
glutaryl coenzyme A (HMG-CoA) reductase inhibitor (atorvastatin). Subjects ... Cited by 15 - Related articles - All 10 versions
- ►jlr.org S Lamon-Fava, MR Diffenderfer, PHR Barrett, … - The Journal of Lipid Research, 2007 - ASBMB Nine hypercholesterolemic and hypertriglyceridemic subjects were enrolled in a
randomized, placebo-controlled, double-blind, crossover study to test the effect
of atorvastatin 20 mg/day and 80 mg/day on the kinetics of apolipoprotein ... Cited by 18 - Related articles - All 4 versions
